Related topics

Protagonist Therapeutics: Q1 Earnings Snapshot

May 4, 2021 GMT

NEWARK, Calif. (AP) _ Protagonist Therapeutics Inc. (PTGX) on Tuesday reported a loss of $24 million in its first quarter.

The Newark, California-based company said it had a loss of 54 cents per share.

The results exceeded Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of 57 cents per share.

The biopharmaceutical company posted revenue of $6.2 million in the period.

Protagonist Therapeutics shares have risen 46% since the beginning of the year. In the final minutes of trading on Tuesday, shares hit $29.35, nearly quadrupling in the last 12 months.


This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on PTGX at https://www.zacks.com/ap/PTGX